Clinical Efficacy of In-situ Thrombolysis in Case of Intraventricular Haemorraghia by Aneurysm Rupture

Status

Completed

Phases

Phase 2Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00823485

Enrollment

Registered

2009-01-15

Start date

2005-10-01

Completion date

2009-12-01

Last updated

2026-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Aneurysm, Ruptured, Subarachnoid Hemorrhage

Brief summary

The purpose of this study is to determine the impact of in situ fibrinolysis on the mortality at 30 days in case of subarachnoid hemorrhage.

Interventions

PROCEDUREfibrinolysis in situ

intraventricular injection of actilyse

PROCEDUREdrainage

drainage

Study design

Allocation

RANDOMIZED

Intervention model

FACTORIAL

Primary purpose

TREATMENT

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* subarachnoid hemorrhage by aneurysm rupture * severe intraventricular hemorraghia

Exclusion criteria

* pregnant women * hemostasis disturbance

Design outcomes

Primary

Measure	Time frame
assessment of mortality	at 30 days

Secondary

Measure	Time frame
assessment of morbidity	at 6 months

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 1, 2026